FDA Inspection
Octapharma Plasma, Inc.Octapharma Plasma, Inc. – FDA Inspection, Aug 10, 2015
Record Details
This FDA Inspection record concerns Octapharma Plasma, Inc., with an inspection on August 10, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Octapharma Plasma, Inc.
- Inspection Date
- August 10, 2015
- Product Type
- Biologics
View Company Profile
ID · 52d76d85-6aa1-4db6-8818-5bcdddc91758
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 947463
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(a)SOP compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Octapharma Plasma, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| March 1, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 24, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 21, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 20, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Octapharma Plasma, Inc.
- FDA Inspection 1230736 - 2024-03-01
- FDA Inspection 1053924 - 2018-05-24
- FDA Inspection 824137 - 2013-03-21
- FDA Inspection 824403 - 2013-03-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.